title: Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study.
authors.forename: Y-H
authors.initials: YH
authors.lastname: Jeong
authors.forename: Y
authors.initials: Y
authors.lastname: Park
authors.forename: W C
authors.initials: WC
authors.lastname: Muse
authors.forename: T J
authors.initials: TJ
authors.lastname: Kwon
authors.forename: J-S
authors.initials: JS
authors.lastname: Koh
authors.forename: S-J
authors.initials: SJ
authors.lastname: Hwang
authors.forename: C H
authors.initials: CH
authors.lastname: Kwak
authors.forename: J-Y
authors.initials: JY
authors.lastname: Hwang
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D044466:Asian People / Q000235:genetics; D001241:Aspirin; D000077407:Cilostazol; D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D065731:Cytochrome P-450 CYP2C19; D004334:Drug Administration Schedule; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D005838:Genotype; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D010641:Phenotype; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D010979:Platelet Function Tests; D011446:Prospective Studies; D056910:Republic of Korea / Q000453:epidemiology; D013777:Tetrazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D000077407:Cilostazol; D013988:Ticlopidine; D001241:Aspirin